Skip to main content

Medicines Discovery & Development

We advance global health with innovative medicines, integrating molecular design, structural biology, and novel delivery systems for safer, effective therapies.

About our division


Through both prevention and cure, our research in drug discovery and advanced therapeutics addresses the major health challenges of our times. We integrate chemistry, biology, pharmacology and formulation science to create small molecules, peptides and biologics, uncover their mechanisms, and improve delivery. We address cancer, neurodegeneration, autoimmunity, infection and antimicrobial resistance, while advancing nanomedicine, biomaterials and targeted delivery.

Focus areas:

  • design and synthesis of novel small molecules, peptides, and biomaterials
  • structural biology and biophysical studies for drug discovery and target validation
  • computational and mechanistic approaches to drug action
  • advanced formulation science and drug delivery technologies
  • development of tools for regulatory science and drug detection
  • nanomedicine and targeted therapies
  • pharmacokinetics: drug disposition and modelling
  • overcoming antimicrobial resistance and improving drug efficacy
handheld spice detection devices laid out in a circle

Our people

Find out more about our members and their research.


News

Read news and updates from our Division.


Meet our researchers


Dr Scott Lovell is a senior lecturer in the Department of Life Sciences, here you can watch Dr Lovell and his team discuss how macrocyclic peptides can be used to inhibit ‘undruggable’ cancer proteins and how this could potentially provide new treatment options for patients.

About us

Our research in drug discovery and advanced therapeutics tackles major health challenges through prevention and cure. We unite medicinal chemistry, structural biology, pharmacology, and formulation science to create new medicines and optimise delivery. We develop small molecules, peptides, and biologics, uncover their mechanisms, and advance technologies for barriers, personalised medicine, and diseases including cancer, neurodegeneration, autoimmunity, infection, and antimicrobial resistance.


Contact us

If you have any questions about our research division, please contact us.